Back
 AiM  Vol.8 No.1 , January 2018
A Review of Staphylococcus aureus and the Emergence of Drug-Resistant Problem
Abstract: There are various bacteria living in this world. The most common one is Staphylococcus aureus. Almost everyone has heard of it. It is easy to find their habitats, such as hospitals, homes, parks, schools etc. Some of them are difficult to be eliminated because of drug-resistant mutations. Hence, lots of researchers devoted their efforts to eliminate them. This review illustrates the characteristics of the Staphylococcus aureus and the main threat of their drug-resistant strains, especially methicillin-resistant S. aureus. What’s more, the article also highlights the plight in the drug development.
Cite this paper: Li, Z. (2018) A Review of Staphylococcus aureus and the Emergence of Drug-Resistant Problem. Advances in Microbiology, 8, 65-76. doi: 10.4236/aim.2018.81006.
References

[1]   Kloos, W.E. (1997) Taxonomy and Systematic of Staphylococci Indigenous to Humans. In: Crossley, K.B. and Archer, G.L., Eds., The Staphylococci in Human Disease, Churchill Livingstone, New York, 113-137.

[2]   Wilson, LG. (1987) The Early Recognition of Streptococci as Causes of Disease. Medical History, 31, 403-414.
https://doi.org/10.1017/S0025727300047268

[3]   Rosenbach, F.J. (1884) Microorganisms in the Wound Infections Diseases of Man. J.F. Bergmann, Wiesbaden, 18.

[4]   Stryjewski, M.E. and Corey, G.R. (2014) Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen. Clinical Infectious Diseases, 58, S10-S19.
https://doi.org/10.1093/cid/cit613

[5]   Wertheim, H.F., Melles, D.C., Vos, M.C., et al. (2005) The Role of Nasal Carriage in Staphylococcus aureus Infections. The Lancet Infectious Diseases, 5, 751-762.
https://doi.org/10.1016/S1473-3099(05)70295-4

[6]   Lowy, F.D. (1998) Staphylococcus aureus Infections. The New England Journal of Medicine, 339, 520-532.
https://doi.org/10.1056/NEJM199808203390806

[7]   Peacock, S.J. and Paterson, G.K. (2015) Mechanisms of Methicillin Resistance in Staphylococcus aureus. Annual Review of Biochemistry, 84, 577–601.
https://doi.org/10.1146/annurev-biochem-060614-034516

[8]   Tong, S.Y.C., Davis, J.S., Eichenberger, E., et al. (2015) Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clinical Microbiology Reviews, 28, 603-661.
https://doi.org/10.1128/CMR.00134-14

[9]   Vandenesch, F., Lina, G. and Henry, T. (2012) Staphylococcus aureus Hemolysins, bi-Component Leukocidins, and Cytolytic Peptides: A Redundant Arsenal of Membrane-Damaging Virulence Factors? Frontiers in Cellular and Infection Microbiology, 2, 2-13.
https://doi.org/10.3389/fcimb.2012.00012

[10]   Costerton, J.W., Lewandowski, Z., Caldwell, D.E., et al. (1995) Microbial Biofilms. Annual Review of Microbiology, 49, 711–745.
https://doi.org/10.1146/annurev.mi.49.100195.003431

[11]   Otto, M. (2013) Staphylococcal Infections: Mechanisms of Biofilm Maturation and Detachment as Critical Determinants of Pathogenicity. Annual Review of Medicine, 64, 175-188.
https://doi.org/10.1146/annurev-med-042711-140023

[12]   Amulic, B., Cazalet, C., Hayes, G.L., Metzler, K.D. and Zychlinsky, A. (2012) Neutrophil Function: From Mechanisms to Disease. Annual Review of Immunology, 30, 459-489.
https://doi.org/10.1146/annurev-immunol-020711-074942

[13]   Spaan, A.N., Surewaard, B.G.J., Nijland, R., et al. (2013) Neutrophils versus Staphylococcus aureus: A Biological Tug of War. Annual Review of Microbiology, 67, 629-650.
https://doi.org/10.1146/annurev-micro-092412-155746

[14]   Greenlee-Wackera, M., DeLeod, F.R. and Nauseef, W.M. (2015) How Methicillin-Resistant Staphylococcus aureus Evade Neutrophil Killing. Wolters Kluwer Health, 22, 31-35.

[15]   Boucher, H.W. and Corey, G.R. (2008) Epidemiology of Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases, 46, S344-S349.
https://doi.org/10.1086/533590

[16]   Archer, G.L. (1998) Staphylococcus aureus: A Well-Armed Pathogen. Clinical Infectious Diseases, 26, 1179-1181.
https://doi.org/10.1086/520289

[17]   Baker, A.D.L. and Macnicol, M.F. (2008) Haematogenous Osteomyelitis in Children: Epidemiology, Classification, Aetiology and Treatment. Journal of Paediatrics and Child Health, 18, 75-84.
https://doi.org/10.1016/j.paed.2007.11.002

[18]   Shorr, A.F., Tabak, Y.P., Gupta, V., et al. (2006) Morbidity and Cost Burden of Methicillin-Resistant Staphylococcus aureus in Early Onset Ventilator Associated Pneumonia. Critical Care, 10, R97.
https://doi.org/10.1186/cc4934

[19]   Lambert, M.L., Suetens, C., Savey, A., et al. (2011) Clinical Outcomes of Health-Care-Associated Infections and Antimicrobial Resistance in Patients Admitted to European Intensive-Care Units: A Cohort Study. The Lancet Infectious Diseases, 11, 30-38.
https://doi.org/10.1016/S1473-3099(10)70258-9

[20]   Cosgrove, S.E., Qi, Y., Kaye, K.S., et al. (2005) The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges. Infection Control and Hospital Epidemiology, 26, 166-174.
https://doi.org/10.1086/502522

[21]   McHugh, C.G. and Riley, L.W. (2004) Risk Factors and Costs Associated with Methicillin-Resistant Staphylococcus aureus bloodstream infections. Infection Control and Hospital Epidemiology, 25, 425-430.
https://doi.org/10.1086/502417

[22]   Klevens, R.M., Morrison, M.A., Nadle, J., et al. (2007) Invasive Methicillin Resistant Staphylococcus aureus Infections in the United States. JAMA, 298, 1763-1771.
https://doi.org/10.1001/jama.298.15.1763

[23]   Chang, V.S., Dhaliwal, D.K., et al. (2015) Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: A 20-Year Review. Wolters Kluwer Health, 34, 698-703.
https://doi.org/10.1097/ICO.0000000000000431

[24]   Paterson, G.K., Harrison, E.M. and Holmes, M.A. (2014) The Emergence of mecC Methicillin-Resistant Staphylococcus aureus. Trends in Microbiology, 22, 42-47.
https://doi.org/10.1016/j.tim.2013.11.003

[25]   National Nosocomial Infections Surveillance (NNIS) (2004) System Report, Data Summary from January 1992 through June 2004, Issued October 2004. American Journal of Infection Control, 32, 470-485.
https://doi.org/10.1016/j.ajic.2004.10.001

[26]   Chambers, H.F. (2001) The Changing Epidemiology of Staphylococcus aureus? Emerging Infectious Diseases, 7, 178-182.
https://doi.org/10.3201/eid0702.010204

[27]   Grundmann, H., Aires-de-Sousa, M., Boyce, J., et al. (2006) Emergence and Resurgence of Meticillin-Resistant Staphylococcus aureus as a Public-Health Threat. The Lancet, 368, 874-885.
https://doi.org/10.1016/S0140-6736(06)68853-3

[28]   Centers for Disease Control and Prevention (1999) Four Pediatric Deaths from Community-Acquired Methicillin-Resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA, 282, 1123-1125.

[29]   Herold, B.C., Immergluck, L.C., Maranan, M.C., et al. (1998) Community-Acquired Methicillin-Resistant Staphylococcus aureus in Children with No Identified Predisposing Risk. JAMA, 279, 593-598.
https://doi.org/10.1001/jama.279.8.593

[30]   Boye, K., Bartels, M.D., Andersen, I.S., et al. (2007) A New Multiplex PCR for Easy Screening of Methicillin-Resistant Staphylococcus aureus SCCmec Types I-V. Clinical Microbiology and Infection, 13, 725-727.
https://doi.org/10.1111/j.1469-0691.2007.01720.x

[31]   Gostev, V.V. and Sidorenko, S.V. (2012) Staphylococcal Cassette Chromosome Mec, Evolution and Genetic Lines of Methicillin-Resistant Staphylococcus aureus. Antibiotiki i khimioterapiia, 57, 38-46.

[32]   Al-Zubeidi, D., Hogan, P.G., Boyle, M., et al. (2014) Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolated in Serial Cultures from the Respiratory Tract of Children with Cystic Fibrosis. Pediatric Infectious Disease Journal, 33, 549-553.
https://doi.org/10.1097/INF.0000000000000204

[33]   Anonymity (2010) MRSA Infections Decline, But New Bacterial Strains Threaten. You Can Take Action to Protect Yourself against Drug-Resistant Bacteria. Duke Medicine Health News, 16, 7.

[34]   Perencevich, E.N. and Diekema, D.J. (2010) Decline in Invasive MRSA Infection: Where to Go from Here? JAMA, 304, 687-689.
https://doi.org/10.1001/jama.2010.1125

[35]   Usui, J., Kobayashi, M., Ebihara, I., et al. (2011) Methicillin-Resistant Staphylococcus-aureus-Associated Glomerulonephritis on the Decline: Decreased Incidence since the 1990s. Clinical and Experimental Nephrology, 15, 184-186.
https://doi.org/10.1007/s10157-010-0369-x

[36]   Eells, S.J., Mckinnell, J.A., Wang, A.A., et al. (2013) A Comparison of Clinical Outcomes between Healthcare-Associated Infections Due to Community-Associated Methicillin-Resistant Staphylococcus aureus Strains and Healthcare-Associated Methicillin-Resistant S. aureus Strains. Epidemiology and Infection, 141, 1-14.
https://doi.org/10.1017/S0950268812002634

[37]   Gottlieb, T., Su, W.Y., Merlino, J., et al. (2008) Recognition of USA300 Isolates of Community-Acquired Methicillin-Resistant Staphylococcus aureus in Australia. The Medical Journal of Australia, 189, 179-180.

[38]   Tenover, F.C. and Goering, R.V. (2009) Methicillin-Resistant Staphylococcus aureus Strain USA300: Origin and Epidemiology. Journal of Antimicrobial Chemotherapy, 64, 441-446.
https://doi.org/10.1093/jac/dkp241

[39]   Larsen, A.R., Bocher, S., Stegger, M., et al. (2008) Epidemiology of European Community-Associated Methicillin-Resistant Staphylococcus aureus Clonal Complex 80 Type IV Strains Isolated in Denmark from 1993 to 2004. Journal of Clinical Microbiology, 46, 62-68.
https://doi.org/10.1128/JCM.01381-07

[40]   Moellering, R.C. (2010) Why Has Methicillin-Resistant Staphylococcus aureus Become Such a Successful Pathogen in Adults? Infectious Diseases in Clinical Practice, 18, 286-291.
https://doi.org/10.1097/IPC.0b013e3181efebca

[41]   Uhlemann, A.-C., Otto, M., Lowy, F.D., et al. (2014) Evolution of Community- and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus. Infection, Genetics and Evolution, 21, 563-574.
https://doi.org/10.1016/j.meegid.2013.04.030

[42]   Levine, D.P., Cushing, R.D., Jui, J., et al. (1982) Community-Acquired Methicillin-Resistant Staphylococcus aureus Endocarditis in the Detroit Medical Center. Annals of Internal Medicine, 97, 330-338.
https://doi.org/10.7326/0003-4819-97-3-330

[43]   Udo, E.E., Pearman, J.W. and Grubb, W.B. (1993) Genetic Analysis of Community Isolates of Methicillin-Resistant Staphylococcus aureus in Western Australia. Journal of Hospital Infection, 25, 97-108.
https://doi.org/10.1016/0195-6701(93)90100-E

[44]   Dufour, P., Gillet, Y., Bes, M., et al. (2002) Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in France: Emergence of a Single Clone That Produces Panton-Valentine Leukocidin. Clinical Infectious Diseases, 35, 819-824.
https://doi.org/10.1086/342576

[45]   Ma, X.X., Galiana, A., Pedreira, W., et al. (2005) Community-Acquired Methicillin-Resistant Staphylococcus aureus, Uruguay. Emerging Infectious Diseases, 11, 973-976.
https://doi.org/10.3201/eid1106.041059

[46]   Wang, C.C., Lo, W.T., Chu, M.L., et al. (2004) Epidemiological Typing of Community-Acquired Methicillin-Resistant Staphylococcus aureus Isolates from Children in Taiwan. Clinical Infectious Diseases, 39, 481-487.
https://doi.org/10.1086/422642

[47]   Pallin, D.J., Egan, D.J., Pelletier, A.J., et al. (2008) Increased US Emergency Department Visits for Skin and Soft Tissue Infections, and Changes in Antibiotic Choices, during the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus. Annals of Emergency Medicine, 51, 291-298.
https://doi.org/10.1016/j.annemergmed.2007.12.004

[48]   Moran, G.J., Krishnadasan, A., Gorwitz, R.J., et al. (2006) Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department. New England Journal of Medicine, 355, 666-674.
https://doi.org/10.1056/NEJMoa055356

[49]   Nimmo, G.R. (2012) USA300 Abroad: Global Spread of a Virulent Strain of Community-Associated Methicillin-Resistant Staphylococcus aureus. Clinical Microbiology and Infection, 18, 725-734.
https://doi.org/10.1111/j.1469-0691.2012.03822.x

[50]   Thurlow, L.R., Joshi, G.S. and Richardson, A.R. (2012) Virulence Strategies of the Dominant USA300 Lineage of Community Associated Methicillin Resistant Staphylococcus aureus (CA-MRSA). FEMS Immunology & Medical Microbiology, 65, 5-22.
https://doi.org/10.1111/j.1574-695X.2012.00937.x

[51]   King, M.D., Humphrey, B.J., Wang, Y.F., et al. (2006) Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections. Annals of Internal Medicine, 144, 309-317.
https://doi.org/10.7326/0003-4819-144-5-200603070-00005

[52]   Reyes, J., Rincon, S., Diaz, L., et al. (2009) Dissemination of Methicillin-Resistant Staphylococcus aureus USA300 Sequence Type 8 Lineage in Latin America. Clinical Infectious Diseases, 49, 1861-1867.
https://doi.org/10.1086/648426

[53]   Hota, B., Lyles, R., Rim, J., et al. (2011) Predictors of Clinical Virulence in Community-Onset Methicillin-Resistant Staphylococcus aureus Infections. Clinical Infectious Diseases, 53, 757-765.
https://doi.org/10.1093/cid/cir472

[54]   Dantes, R., Mu, Y., Belflower, R., et al. (2013) National Burden of Invasive Methicillin-Resistant Staphylococcus aureus Infections, United States, 2011. JAMA Internal Medicine, 173, 1970-1978.

[55]   Nimmo, G.R., Pearson, J.C., Collignon, P.J., et al. (2011) Antimicrobial Susceptibility of Staphylococcus aureus Isolated from Hospital Inpatients, 2009: Report from the Australian Group on Antimicrobial Resistance. Communicable Diseases Intelligence, 35, 237-243.

[56]   Styers, D., Sheehan, D.J., Hogan, P., et al. (2006) Laboratory-Based Surveillance of Current Antimicrobial Resistance Patterns and Trends among Staphylococcus aureus: 2005 Status in the United States. Annals of Clinical Microbiology and Antimicrobials, 5, 1-9.
https://doi.org/10.1186/1476-0711-5-1

[57]   Public Health England (2013) Voluntary Reporting of Staphylococcus aureus Bacteraemia in England, Wales and Northern Ireland, 2012. Health Protection Report.

[58]   Huang, Y.-C. and Chen, C.-J. (2011) Community-Associated Meticillin-Resistant Staphylococcus aureus in Children in Taiwan, 2000s. International Journal of Antimicrobial Agents, 38, 2-8.
https://doi.org/10.1016/j.ijantimicag.2011.01.011

[59]   Otter, J.A. and French, G.L. (2010) Molecular Epidemiology of Community-Associated Meticillin-Resistant Staphylococcus aureus in Europe. Lancet Infectious Diseases, 10, 227-239.
https://doi.org/10.1016/S1473-3099(10)70053-0

[60]   Rammelkamp, C.H. and Maxon, T. (1942) Resistance of Staphylococcus aureus to the Action of Penicillin. Experimental Biology and Medicine, 51, 386-389.
https://doi.org/10.3181/00379727-51-13986

[61]   Bondi, A. and Dietz, C.C. (1945) Penicillin Resistant Staphylococci. Experimental Biology and Medicine, 60, 55-58.
https://doi.org/10.3181/00379727-60-15089

[62]   Kirby, W.M. (1944) Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci. Science, 99, 452-453.
https://doi.org/10.1126/science.99.2579.452

[63]   Finland, M. (1955) Emergence of Antibiotic-Resistant Bacteria. New England Journal of Medicine, 253, 909-922.
https://doi.org/10.1056/NEJM195511242532105

[64]   Brumfitt, W. and Hamilton-Miller, J. (1989) Methicillin-Resistant Staphylococcus aureus. New England Journal of Medicine, 320, 1188-1196.
https://doi.org/10.1056/NEJM198905043201806

[65]   Jessen, O., Rosendal, K., Bulow, P., Faber, V., Eriksen, K.R. (1969) Changing Staphylococci and Staphylococcal Infections. A Ten-Year Study of Bacteria and Cases of Bacteremia. New England Journal of Medicine, 281, 627-635.
https://doi.org/10.1056/NEJM196909182811201

[66]   Jevons, M.P. (1961) “Celbenin”-Resistant Staphylococci. British Medical Journal, 1, 124-125.
https://doi.org/10.1136/bmj.1.5219.124-a

[67]   Stefani, S., Campanile, F., Santagati, M., et al. (2015) Insights and Clinical Perspectives of Daptomycin Resistance in Staphylococcus aureus: A Review of the Available Evidence. International Journal of Antimicrobial Agents, 8, 1-12.

[68]   Centers for Disease Control and Prevention (CDC) (2002) Staphylococcus aureus Resistant to Vancomycin—United States, 2002. MMWR. Morbidity and Mortality Weekly Report, 51, 565-567.

[69]   Lowy, F.D. (2003) Antimicrobial Resistance: The Example of Staphylococcus aureus. Journal of Clinical Investigation, 111, 1265-1273.
https://doi.org/10.1172/JCI18535

[70]   Malachowa, N. and DeLeo, F.R. (2010) Mobile Genetic Elements of Staphylococcus aureus. Cellular and Molecular Life Sciences, 67, 3057-3071.
https://doi.org/10.1007/s00018-010-0389-4

 
 
Top